Angiotech commences first peripheral by-pass study using drug-loaded vascular wrap.

(From Chemical Business NewsBase - Press Release)

Angiotech Pharmaceuticals Inc (Angiotech) has commenced enrolment in a European study of its first human peripheral by-pass study, which will evaluate a proprietary drug-loaded vascular wrap. The drug-loaded wrap is designed to prevent or reduce stenosis at the by-pass attachment site. Patients diagnosed with peripheral vascular disease undergoing "below the knee" femoral-popliteal arterial by-pass surgery, will receive a traditional graft or a graft plus Angiotech's paclitaxel-loaded biodegradable vascular wrap. When applied to the outside wall of the vessel, the wrap delivers drug to the blood vessel wall in a …